Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats

Neuroendocrinology

Volumn 70, Issue 2, 1999, Pages 93-100

  Luckman, Simon M ^a   Rosenzweig, Ivana ^b   Dickson, Suzanne L ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

Fasting; Growth hormone; Growth hormone secretagogues; Leptin; Neuropeptide Y; Pro opiomelanocortin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; LEPTIN; NEUROPEPTIDE Y; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DIET RESTRICTION; GROWTH HORMONE RELEASE; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PULSE GENERATOR; RAT;

ANIMALS; ARCUATE NUCLEUS; FASTING; GENE EXPRESSION; GENES, FOS; GROWTH HORMONE-RELEASING HORMONE; HORMONES; IMMUNOHISTOCHEMISTRY; LEPTIN; MALE; NEURONS; NEUROPEPTIDE Y; OLIGOPEPTIDES; RATS;

EID: 0032855954     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054463     Document Type: Article

References (53)

1. Tannenbaum GS, Rorstad O, Brazeau P: Effects of prolonged food deprivation on the ultradian growth hormone rhythm and immunoreactive somatostatin tissue levels in the rat. Endocrinology 1979;104:1733-1738.
2. Jacobowitz DM, Schulte H, Chrousos GP, Loriaux DL: Localization of GRF-like immunoreactive neurons in the rat brain. Peptides 1983;4:521-524.
3. Guilleman R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB: Growth hormone-releasing factor from a human pancreatic tumor that causes acromegaly. Science 1982;218: 585-587.
4. Rivier J, Speiss J, Thorner M, Vale W: Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982;300:276-278.
5. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R: Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
6. Ishikawa K, Taniguchi Y, Kurosumi K, Suzuki M, Shinoda M: Immunohistochemical identification of somatostatin-containing neurons projecting to the median eminence. Endocrinology 1987;121:94-97.
7. Bruno JF, Olchovsky D, White JD, Leidy JW, Song J, Berelowitz M: Influence of food deprivation in the rat on hypothalamic expression of growth-hormone releasing factor and somatostatin. Endocrinology 1990;127:2111-2116.
8. Hugues JN, Enjalbert A, Moyse E, Shu C, Voirol MJ, Sebaaoun J, Epelbaum J: Differential effects of passive immunization with somatostatin antiserum on adenohypophysial hormone secretions in starved rats. J Endocrinol 1986;109:169-174.
9. Vaugnat BAM, Pierroz DD, Lalaoui M, Englaro P, Pralong FP, Blum WF, Aubert ML: Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat. Neuroendocrinology 1998;67:291-300.
10. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C: Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997;138:2203-2206.
11. Tannenbaum GS, Gurd W, Lapointe M: Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH respone to GH-releasing hormone. Endocrinology 1998;139:3871-3875.
12. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269: 546-549.
13. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
14. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269: 540-543.
15. Zhang Y, Proenca R, Maffei M, Barone M, Lepold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
16. Hakansson M-L, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572.
17. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113-116.
18. Fei H, Okano HJ, Li C, Lee G-H, Zhao C, Darnell R, Friedman JM: Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997;94:7001-7005.
19. Quintela M, Senaris R, Heiman ML, Casanucva FF, Dieguez C: Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology 1997; 138:5641-5644.
20. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P: Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733-735.
21. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
22. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531-535.
23. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffman J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377: 530-532.
24. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
25. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 1990;52: 441-447.
26. Thornton JE, Cheung CC, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066.
27. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects. Nature 1997;390:349.
28. Bowers CY, Momany FA, Reynolds GA, Hong A: On the in vitro and in vitro activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1537-1545.
29. Guan X-M, Yu H, Palyha OC, McKee KK, Feigher SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD: Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997;48:23-29.
30. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD: Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 1998;139:4420-4423.
31. Dickson SL, Leng G, Ronbinson ICAF: Systemic administration of growth hormone-releasing peptide (GHRP-6) activates hypothalamic arcuate neurones. Neuroscience 1993;53: 303-306.
32. Dickson SL, Luckman SM: Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue. GH-releasing peptide-6. Endocrinology 1997; 138:771-777.
33. Kamegai J, Hasegawa O, Minami S, Sugihara H, Wakabayashi I: The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus. Mol Brain Res 1996;39:153-159.
34. Baskin DG, Seeley RJ, Kuijper JL, Lok S, Weigle DS, Erickson JC, Palmiter RD, Schwartz MW: Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes 1998;47:538-543.
35. Lin S, Huang XF: Fasting increases leptin receptor mRNA expression in lean but not obese (ob/ob) mouse brain. Neuroreport 1997;8: 3625-3629.
36. Bennett PA, Lindell K, Karlsson C, Robinson ICAF, Carlsson LM, Carlsson B: Differential expression and regulation of leptin receptor isoforms in the rat brain: Effects of fasting and oestrogen. Neuroendocrinology 1998;67:29-36.
37. Luckman SM, Rosenzweig I, Dickson SL: Modulation of arcuate neuron activity by GHRP-6 and leptin in normal and fasted rats. Soc Neurosci Abstr 1997;23:144.
38. Murphy TM, Worley PF, Barban JM: L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. Neuron 1991;7:625-635.
39. Swanson LW: Brain Maps: Structure of the Rat Brain. Amsterdam, Elsevier, 1992.
40. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M: Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 1993;14:303-347.
41. Chomczynski P, Downs TR, Frohman LA: Feedback regulation of growth hormone releasing hormone gene expression by growth hormone in rat hypothalamus. Mol Endocrinol 1988;2:236-241.
42. Chan YY, Steiner RA, Clifton DK: Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology 1996;137:1319-1325.
43. Dickson SL, Doutrelant-Viltart O, Leng G: GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol 1995; 146:519-526.
44. Glaum SR, Hara M, Bindokas VP, Lee CC, Polonsky S, Bell GI, Miller RJ: Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996;50:230-235.
45. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford MLJ: Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997;390:521-525.
46. Woods AJ, Stock MJ: Leptin activation in hypothalamus. Nature 1996;381:745.
47. Elias CF, Lee C, Kelly J, Aschkensai C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, Elmquist JK: Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 1998;21:1375-1385.
48. Elmquist JK, Ahima RS, Maratos-Flier E, Flier J-S, Saper CB: Leptin activates neurons in the ventrobasal hypothalamus and brainstem. Endocrinology 1997;138:839-842.
49. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB: Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 1998; 95:741-746.
50. Kim E-M, Welch CC, Grace MK, Billington CJ, Levine AS: Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. Am J Physiol 1996;270:R1019-1024.
51. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortin neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168.
52. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Hang Q, Berkmeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
53. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998;393: 72-76.